Table 2.
Summary of univariate analysis for glycomic profiles of basigin from tumor (T) and non-tumor (N) regions.
| Lectin | Pa | Median (N) | Median (T) | |FC(log2[T/N])|b | Summary |
|---|---|---|---|---|---|
| MAL-I | 0.0001 | 0.15 | 0.49 | 1.7 | Up |
| STL | 0.0001 | 2.10 | 3.29 | 0.6 | Up |
| LEL | 0.0009 | 6.20 | 8.45 | 0.4 | Up |
| TJA-I | 0.0012 | 0.79 | 1.63 | 1.0 | Up |
| ACG | 0.0012 | 3.73 | 6.39 | 0.8 | Up |
| SNA | 0.0067 | 0.75 | 1.21 | 0.7 | Up |
| BPL | 0.017 | 0.01 | 0.03 | 1.2 | Up |
| SSA | 0.025 | 0.75 | 1.15 | 0.6 | Up |
| RCA120 | 0.025 | 0.48 | 0.62 | 0.4 | Up |
| PHA-E | 0.025 | 0.12 | 0.17 | 0.5 | Up |
| EEL | 0.0002 | 0.08 | 0.00 | 6.1 | Down |
| ConA | 0.0004 | 0.30 | 0.18 | 0.7 | Down |
| PTL-I | 0.0010 | 0.15 | 0.00 | >10 | Down |
| DSA | 0.0023 | 8.99 | 6.19 | 0.5 | Down |
| GSL-I-A4 | 0.0039 | 0.03 | 0.00 | >10 | Down |
| TJA-II | 0.0052 | 0.11 | 0.04 | 1.4 | Down |
| DBA | 0.0061 | 0.47 | 0.00 | 9.2 | Down |
| WGA | 0.0085 | 3.61 | 0.65 | 2.5 | Down |
| Jacalin | 0.098 | 0.00 | 0.00 | N.D. | – |
| PHA-L | 0.11 | 0.00 | 0.00 | N.D. | – |
| MAH | 0.11 | 0.00 | 0.00 | N.D. | – |
| UEA-I | 0.13 | 0.01 | 0.01 | 0.2 | – |
| GNA | 0.21 | 0.01 | 0.00 | 3.3 | – |
| HHL | 0.46 | 0.07 | 0.07 | 0.0 | – |
| ACA | 0.46 | 0.02 | 0.01 | 1.6 | – |
| GSL-I-B4 | 0.50 | 0.00 | 0.00 | N.D. | – |
| NPA | 0.51 | 0.08 | 0.05 | 0.6 | – |
| LTL | 0.63 | 0.00 | 0.00 | N.D. | – |
| GSL-II | 0.65 | 0.00 | 0.00 | N.D. | – |
| AAL | 0.76 | 4.33 | 4.92 | 0.2 | – |
| Calsepa | 0.76 | 0.20 | 0.18 | 0.2 | – |
| ECA | 0.81 | 0.08 | 0.06 | 0.4 | – |
| AOL | 0.86 | 1.90 | 3.18 | 0.7 | – |
| WFA | > 0.99 | 0.00 | 0.00 | N.D. | – |
| SBA | > 0.99 | 0.00 | 0.00 | N.D. | – |
| PWM | 1.00 | 0.00 | 0.00 | N.D. | – |
| PNA | 1.00 | 0.00 | 0.00 | N.D. | – |
| MPA | 1.00 | 0.00 | 0.00 | N.D. | – |
| HPA | 1.00 | 0.00 | 0.00 | N.D. | – |
| PSA | N.D. | 0.45 | 0.63 | 0.5 | – |
| LCA | N.D. | 0.84 | 1.13 | 0.4 | – |
| TxLC-I | N.D. | 0.25 | 0.27 | 0.1 | – |
| ABA | N.D. | 0.86 | 0.83 | 0.1 | – |
| UDA | N.D. | 1.45 | 1.91 | 0.4 | – |
| VVA | N.D. | 0.11 | 0.19 | 0.8 | – |
a
N.D., not determined due to the high background caused by the detection antibody.
b
The significant changes (|FC(log2[T/N])| > 1) are highlighted in bold. N.D., not determined due to the zero values for the non-tumor samples.